Financial insights of ENTXW

MyFinsight

For the quarter ending 2026-03-31.

Income Statement	2026-03-31	2025-09-30	2025-06-30
Revenues	0	0	0
Cost of revenue	0	0	0
Gross profit	0	0	0
Research and development expense	2,251,000	1,643,000	1,520,000
General and administrative expense	1,288,000	1,613,000	1,148,000
Net expenses related to opko collaboration agreement	3,539,000	3,256,000	2,668,000
Operating loss	-3,539,000	-3,256,000	-2,668,000
Financial (income) expenses, net	34,000	56,000	12,000
Net loss	-3,505,000	-3,200,000	-2,656,000

Basic EPS	0.07	0.07	0.06
Diluted EPS	0.07	0.07	0.06
Basic Average Shares	47,756,409	47,089,814	46,836,700
Diluted Average Shares	47,756,409	47,089,814	46,836,700

Unit: Dollar. Numbers labeled with * are estimated quarterly values.